| |
|
|
|
GTCbio, Boston,MA
March 9-10 , 2009
The 5th annual Stem Cell Research & Therapeutics Conference provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells. As alternative sources of human embryonic stem cells emerge, new and exciting federal funding opportunities are arising.
The conference will review recent developments in policies regarding funding for Stem Cell Research. Private funding from the Pharmaceutical Industry will also be addressed. These and other questions will be the highlight of GTCbio`s 2009 Stem Cell Research and Therapeutics conference. Sessions for the conference include: • Differentiation of Stem Cells
• Induced Pluripotent Cells, Reprogramming & Epigenomics
• Regenerative Medicine & Tissue Engineering
• Stem Cell In vivo and Molecular Imaging
• Regulatory Aspects, Commercialization & Funding Opportunities
• Cancer Stem Cells
• Stem Cell Applications in Drug Discovery
• Pre-Clinical & Clinical Trials of Stem Cell Therapy
• Technology in Stem Cell Research
This event provides a unique venue for attendees to network and meet with leading experts in the most comfortable and informal of settings.
|
|
|
|
|
|
|
|
Organized by:
|
|
GTCbio |
|
|
Invited Speakers:
|
|
| | DISTINGUISHED SPEAKERS & ADVISORS:
Kazuhiro Aiba
Senior Scientist
SCDI
Anne Bang
Associate Director, Stem Cell Technologies
Novocell, Inc.
Miriam Bibel
Senior Research Investigator / Project Team Head, Neurodegeneration
Novartis
Petter Bjorquist
Ph.D., Senior Principal Scientist, Project Manager
Cellartis AB
Gregory A. Bonfiglio
Managing Partner
Proteus Venture Partners
Yen Choo, Ph.D.
CEO
Plasticell Limited
Aaron T. Chuang
Manager Cellular Neurobiology
GlaxoSmithKline
Jay Edelberg
Group Director - Clinical Biomarkers, Discovery Medicine & Clinical Pharmacology DMCP
Bristol-Myers Squibb Co.
Kurt C Gunter, M.D.
Global Medical Director, Regenerative Medicine
Hospira, Inc.
Robert M. Hoffman, Ph.D.
President
AntiCancer, Inc.
Professor of Surgery
University of California, San Diego
Johnny Huard
University of Pittsburgh Stem Cell Research Center
Edward Lanphier
President & Chief Executive Officer
Sangamo BioSciences
Tracey Lodie
Associate Director
Genzyme
Bradley J. Martin, Ph.D.
Director - Product Development
Aastrom
David Schaffer
Professor, Chemical Engineering, Bioengineering & The Helen Wills Neuroscience Institute
UC Berkeley
Geoff Symonds
Senior Research Director & Global Product Leader, HIV Gene Therapy
Johnson & Johnson Research
Anthony Ting, Ph.D.
Director, Regenerative Medicine
Athersys, Inc.
Chunhui Xu
Group Leader
Geron
Philip Wright
Chief Executive
Stem Cells for Safer Medicines Ltd.
|
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
February 10th 2009
|
|
|
|
|
|
|
|
Registration:
|
|
https://gtcbio.com/userpart/user_registration.aspx
|
|
|
E-mail:
|
|
raniah@gtcbio.com
|
|
|
|
|
|
|
|
|